SMAD3 and hypertensive heart disease: ,7,8,9,10,11,12 Among TGF-β/Smad signaling, Smad3 is pathogenic because genetic deletion or pharmacological inhibition of Smad3 can protect against Ang II-induced hypertensive cardiopathy and nephropathy.10